Dr. Lal PathLabs (NSE:LALPATHLAB) E10: ₹22.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LALPATHLAB Dr. Lal PathLabs Ltd NSE:LALPATHLAB
93 GF Score
Price ₹1,949.90
GF Value ₹1,735.83
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Dr. Lal PathLabs E10?

Dr. Lal PathLabs NSE:LALPATHLAB -0.21% 93 E10 is ₹22.25 as of Jun. 2026. GuruFocus rates NSE:LALPATHLAB with a GF Score™ of 93/100 and a GF Value™ of ₹1,735.83 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dr. Lal PathLabs's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹10.130. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹22.25 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Dr. Lal PathLabs's average E10 Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-12), Dr. Lal PathLabs's current stock price is ₹1949.90. Dr. Lal PathLabs's E10 for the quarter that ended in Jun. 2026 was ₹22.25. Dr. Lal PathLabs's Shiller PE Ratio of today is 87.64.

During the past 13 years, the highest Shiller PE Ratio of Dr. Lal PathLabs was 98.94. The lowest was 60.76. And the median was 75.87.


Dr. Lal PathLabs  (NSE:LALPATHLAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dr. Lal PathLabs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1949.90/22.25
=87.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Dr. Lal PathLabs was 98.94. The lowest was 60.76. And the median was 75.87.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dr. Lal PathLabs E10 Related Terms


Dr. Lal PathLabs E10 Historical Data

* Premium members only.

The historical data trend for Dr. Lal PathLabs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs E10 Chart

Dr. Lal PathLabs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 16.75 18.80 21.37

Dr. Lal PathLabs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.55 20.70 20.79 21.37 22.25

NSE:LALPATHLAB vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Shiller PE Ratio falls into.


NSE:LALPATHLAB
93GF Score
Dr. Lal PathLabs Ltd NSE:LALPATHLAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Lal PathLabs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr. Lal PathLabs's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.13/166.1454*166.1454
=10.130

Current CPI (Jun. 2026) = 166.1454.

Dr. Lal PathLabs Quarterly Data

per share eps CPI Adj_EPS
201609 3.215 105.961 5.041
201612 1.875 105.196 2.961
201703 1.920 105.196 3.032
201706 2.700 107.109 4.188
201709 3.090 109.021 4.709
201712 2.195 109.404 3.333
201803 2.435 109.786 3.685
201806 3.000 111.317 4.478
201809 3.450 115.142 4.978
201812 2.775 115.142 4.004
201903 2.850 118.202 4.006
201906 3.565 120.880 4.900
201909 4.875 123.175 6.576
201912 3.275 126.235 4.310
202003 1.970 124.705 2.625
202006 1.720 127.000 2.250
202009 5.155 130.118 6.582
202012 5.705 130.889 7.242
202103 5.045 131.771 6.361
202106 7.920 134.084 9.814
202109 5.725 135.847 7.002
202112 3.450 138.161 4.149
202203 3.710 138.822 4.440
202206 3.480 142.347 4.062
202209 4.300 144.661 4.939
202212 3.165 145.763 3.608
202303 3.410 146.865 3.858
202306 4.965 150.280 5.489
202309 6.560 151.492 7.195
202312 4.880 152.924 5.302
202403 5.085 153.035 5.521
202406 6.380 155.789 6.804
202409 7.740 157.882 8.145
202412 5.790 158.323 6.076
202503 9.270 157.552 9.776
202506 7.930 159.755 8.247
202509 9.005 162.289 9.219
202512 5.410 163.281 5.505
202603 7.850 164.272 7.940
202606 10.130 166.145 10.130

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹22.25 mean?
Dr. Lal PathLabs (NSE:LALPATHLAB) has a E10 of ₹22.25 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dr. Lal PathLabs and its competitors.
Is Dr. Lal PathLabs' E10 too high?
Dr. Lal PathLabs' current E10 is ₹22.25. Overall, Dr. Lal PathLabs has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Lal PathLabs' E10 compare to TMO and DHR?
Dr. Lal PathLabs' E10 of ₹22.25 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dr. Lal PathLabs and its competitors. Dr. Lal PathLabs's current E10 is ₹22.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Lal PathLabs stock overvalued right now?
Based on GuruFocus' analysis, Dr. Lal PathLabs (NSE:LALPATHLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,735.83, compared to a current price of ₹1,949.90 — trading 12.3% above its estimated fair value. The current E10 is ₹22.25. Dr. Lal PathLabs' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Dr. Lal PathLabs (NSE:LALPATHLAB), the current E10 is ₹22.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued. The current stock price of ₹1,949.90 is trading 12.3% above its estimated GF Value™ of ₹1,735.83. GuruFocus considers Dr. Lal PathLabs to be Modestly Overvalued.

Key valuation signals for NSE:LALPATHLAB:

  • E10: ₹22.25
  • GF Value™: ₹1,735.83 vs. price of ₹1,949.90 (12.3% above fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the NSE:LALPATHLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr. Lal PathLabs Business Description

Other Exchanges 539524:India
Address 12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
93GF Score

Get the complete analysis for NSE:LALPATHLAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,949.90
Price
₹1,735.83
GF Value